MS

Mukesh Srivastava

Active Director Director DIN 11290272
DIN 11290272 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukesh Srivastava

Data last updated:

Mukesh Srivastava is a Director at Xenova Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11290272
Primary Designation Director
Industry Pharma
First Appointment 10 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Sep 20252025Active

Board colleagues of Mukesh Srivastava

NameDINCompanyDesignation
Shanni Kumar Srivastava11290273Xenova Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Xenova Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mukesh Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Srivastava

Mukesh Srivastava currently holds 1 directorship: Xenova Pharmaceuticals Private Limited (Director, since 10 Sep 2025).

Mukesh Srivastava was first appointed on 10 Sep 2025 as Director at Xenova Pharmaceuticals Private Limited.

The current boards of Mukesh Srivastava's companies include Shanni Kumar Srivastava (Xenova Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available